OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 58 citing articles:

Relationship between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues
Estefanía Burgos‐Morón, Zaida Abad‐Jiménez, A Marañón, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1385-1385
Open Access | Times Cited: 468

Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives
Jasvinder Singh Bhatti, Abhishek Sehrawat, Jayapriya Mishra, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 114-134
Open Access | Times Cited: 367

Inflammageing and metaflammation: The yin and yang of type 2 diabetes
Francesco Prattichizzo, Valeria De Nigris, Rosangela Spiga, et al.
Ageing Research Reviews (2017) Vol. 41, pp. 1-17
Closed Access | Times Cited: 218

Use of Human Umbilical Vein Endothelial Cells (HUVEC) as a Model to Study Cardiovascular Disease: A Review
Diana Jhoseline Medina-Leyte, Mayra Domínguez‐Pérez, Ingrid Mercado, et al.
Applied Sciences (2020) Vol. 10, Iss. 3, pp. 938-938
Open Access | Times Cited: 181

The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction
Ying An, Bu-tuo Xu, Shengrong Wan, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 127

Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease
Zhan Zhang, Rinkoo Dalan, Zhenyu Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 35
Open Access | Times Cited: 106

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications
Dongrong Yang, Meng‐Yan Wang, Chenglin Zhang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 37

Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication
Sanaz Nasoohi, Saifudeen Ismael, Tauheed Ishrat
Molecular Neurobiology (2018) Vol. 55, Iss. 10, pp. 7900-7920
Open Access | Times Cited: 133

Diabetic nephropathy: New insights into established therapeutic paradigms and novel molecular targets
Dilip Kumar Sharma, Pallab Bhattacharya, Kiran Kalia, et al.
Diabetes Research and Clinical Practice (2017) Vol. 128, pp. 91-108
Closed Access | Times Cited: 127

Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low‐grade inflammation the neglected component?
Francesco Prattichizzo, Valeria De Nigris, Stefano Micheloni, et al.
Diabetes Obesity and Metabolism (2018) Vol. 20, Iss. 11, pp. 2515-2522
Closed Access | Times Cited: 103

Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing
Francesco Prattichizzo, Angelica Giuliani, Emanuela Mensa’, et al.
Ageing Research Reviews (2018) Vol. 48, pp. 87-98
Closed Access | Times Cited: 99

Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients
Habib Yaribeygi, Alexandra E. Butler, George E. Barreto, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 3, pp. 2436-2446
Closed Access | Times Cited: 81

Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway
Esther Civantos, Enrique Bosch, Elisa Ramírez Bustillo, et al.
Diabetes Metabolic Syndrome and Obesity (2017) Vol. Volume 10, pp. 207-222
Open Access | Times Cited: 64

The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target
Alison Domingues, Julia Jolibois, Perrine Marquet de Rougé, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1693-1693
Open Access | Times Cited: 49

Sitagliptin‐mediated preservation of endothelial progenitor cell function via augmenting autophagy enhances ischaemic angiogenesis in diabetes
Xiaozhen Dai, Jun Zeng, Xiaoqing Yan, et al.
Journal of Cellular and Molecular Medicine (2017) Vol. 22, Iss. 1, pp. 89-100
Open Access | Times Cited: 49

High glucose-induced PRDX3 acetylation contributes to glucotoxicity in pancreatic β-cells: Prevention by Teneligliptin
Suma Elumalai, Udayakumar Karunakaran, Jun Sung Moon, et al.
Free Radical Biology and Medicine (2020) Vol. 160, pp. 618-629
Closed Access | Times Cited: 36

The Unique Pharmacological and Pharmacokinetic Profile of Teneligliptin: Implications for Clinical Practice
Antonio Ceriello, Valeria De Nigris, Hiroaki Iijima, et al.
Drugs (2019) Vol. 79, Iss. 7, pp. 733-750
Open Access | Times Cited: 31

Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes
Netanya Y. Spencer, Zhihong Yang, Jensyn Cone Sullivan, et al.
PLoS ONE (2018) Vol. 13, Iss. 7, pp. e0200249-e0200249
Open Access | Times Cited: 27

Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging
Fen Cao, Kun Wu, Yongzhi Zhu, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 18

Teneligliptin Co-Infusion Alleviates Morphine Tolerance by Inhibition of Spinal Microglial Cell Activation in Streptozotocin-Induced Diabetic Rats
Yaswanth Kuthati, Vaikar Navakanth Rao, Wei-Hsiu Huang, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1478-1478
Open Access | Times Cited: 7

Teneligliptin prevents doxorubicin-induced inflammation and apoptosis in H9c2 cells
Wen Peng, Dan Rao, Meng Zhang, et al.
Archives of Biochemistry and Biophysics (2019) Vol. 683, pp. 108238-108238
Closed Access | Times Cited: 20

Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma
Shuhei Kamada, Takeshi Namekawa, Kazuhiro Ikeda, et al.
Oncogene (2021) Vol. 40, Iss. 22, pp. 3899-3913
Closed Access | Times Cited: 16

Incretin-based therapy: a new horizon in diabetes management
Malek Zarei, Navideh Sahebi Vaighan, Mohammad Hadi Farjoo, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 1665-1686
Closed Access | Times Cited: 2

Vildagliptin promotes diabetic foot ulcer healing through autophagy modulation
Erik Biroš, Venkat Vangaveti, Usman H. Malabu
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Perspectives on cardiovascular effects of incretin-based drugs: From bedside to bench, return trip
Michaela Luconi, Giulia Cantini, Antonio Ceriello, et al.
International Journal of Cardiology (2017) Vol. 241, pp. 302-310
Closed Access | Times Cited: 21

Page 1 - Next Page

Scroll to top